However, secondary PDGFRα mutations (Val658Ala, Asn659Lys, Tyr676Cys, and Gly680Arg) have been observed in patients with drug resistant recurrent GIST [25]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.